Vets Plus, Inc. announced that Noble Pharma, LLC, its wholly-owned drug manufacturing facility located in Menomonie, Wisconsin, has successfully completed its initial establishment inspection by the US Food & Drug Administration.
“We could not be prouder of the accomplishments by the entire Noble Pharma team,” said Raj Lall, founder and CEO of Vets Plus, Inc., “In two short years the talented team at Noble Pharma, relying on their extensive experience in human and animal health pharmaceutical manufacturing and Quality Management System, has created a state-of-the-art, FDA-compliant drug facility.”
“We are excited about the opportunities Noble Pharma will allow us to offer our customers,” Mr. Lall continued. “It will help us be the comprehensive contract manufacturing and development partner our customers need across a full range of nutritional products and pharmaceuticals.”
Vets Plus, Inc. is a leading manufacturer of health and nutrition products for livestock and companion animals, operating throughout North America and internationally. A nutritional science innovation leader in the animal health industry, Vets Plus also engages in the development of breakthrough technologies to improve product palatability, support healthy digestive function and ensure normal nutrient uptake in animals. It has recently expanded its vast manufacturing expertise to include solid oral dose drug manufacturing capabilities at its new FDA-approved drug manufacturing facility in Menomonie, Wisconsin (Noble Pharma, LLC). Vets Plus, Inc. is committed to quality and maintains Safe Quality Food (SQF) Edition 8.0 certification, Food Chain Alliance (FCA) certification, NASC membership and AAFCO compliance. For information about Vets Plus, visit www.vets-plus.com.